Showing results (11-20 of 131) with videos related to
Sort By:
Pageof 14
Cancer Letters|May 1, 1985
Diaplacental carcinogenic effects of 5-azacytidine in NMRI-miceW Schmahl, E Geber, W LehmacherThe European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|July 13, 2000
Considerations on the statistical design of the ATMI studyR Eisebitt, W Lehmacher, R LeferingFortschritte Der Medizin|February 28, 1992
[Treatment of acute ankle sprains. Comparison of the efficacy and tolerance of 2 indomethacin-gel preparations]W Diebschlag, W Nocker, W LehmacherBiometrics|June 1, 1991
Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rateW Lehmacher, G Wassmer, P ReitmeirVASA. Zeitschrift Fur Gefasskrankheiten|October 6, 2004
Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IVA Creutzig, W Lehmacher, M ElzeVASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1989
[A 3-month, randomized double-blind dose-response study with 0-(beta-hydroxyethyl)-rutoside oral solutions]W Nocker, W Diebschlag, W LehmacherExplore (New York, N.Y.)|June 20, 2006
Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trialA G Chuchalin, B Berman, W LehmacherFolia Biologica|June 5, 2003
Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trialCh Doehn, A Richter, W Lehmacher, et al.Arzneimittel-Forschung|May 1, 1996
Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administrationD Rehn, H Brunnauer, W Diebschlag, et al.Pageof 14